NEW YORK, March 19, 2024 /PRNewswire/ -- The global cell culture market size is estimated to grow by USD 17.74 bn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of almost 11.3% during the forecast period. North America held the largest share of the global market in 2022, and the market in the region is estimated to witness an incremental growth of 39%. Cell Culture Market report includes information on the product launches, sustainability, and prospects of leading vendors including Agilent Technologies Inc., Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., CLS Cell Lines Service GmbH, Corning Inc., Danaher Corp., Eppendorf AG, FUJIFILM Holdings Corp, General Electric Co., InvivoGen, LABGENE Scientific SA, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PromoCell GmbH, Sartorius AG, Sartorius CellGenix GmbH, Thermo Fisher Scientific Inc., ZenBio Inc. .For more insights on the historic (2017 - 2021) and forecast market size (2023-2027) - Request a sample report
Cell Culture Market Scope |
|
Report Coverage |
Details |
Base year |
2022 |
Historic period |
2017 - 2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 11.3% |
Market growth 2023-2027 |
USD 17.74 billion |
Market structure |
Fragmented |
YoY growth 2022-2023 (%) |
10.61 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key countries |
US, Germany, UK, China, and Japan |
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters.View Sample Report
Research Analyst Overview
The Capacity Market for Cell Culture is a significant and growing sector within the biotechnology industry. Massive investments are being made in this field due to the increasing demand for biopharmaceuticals and therapeutic proteins. The Fisher Scientific CAPTIVATE system, for instance, is a crucial technology used in cell culture processes. This system ensures efficient and high-performing bioprocessing, which is essential for the production of various vaccines and monoclonal antibodies. The Capacity Market for Cell Culture is driven by several factors, including the rising prevalence of chronic diseases, the growing aging population, and the increasing focus on personalized medicine. Additionally, advancements in cell culture technology, such as the use of microcarriers and perfusion bioreactors, have led to increased productivity and cost savings. Thermo Fisher Scientific, a leading player in the cell culture market, offers a range of solutions for cell culture applications. These include media, serums, supplements, and bioreactors. The company's Rubellite bioreactor, for example, is a high-performance, single-use bioreactor designed for the production of mammalian cells. In conclusion, the Capacity Market for Cell Culture is a dynamic and evolving sector that plays a crucial role in the production of biopharmaceuticals and therapeutic proteins. With continued advancements in technology and increasing demand for these products, the market is expected to grow significantly in the coming years.
Market Sizing
The Cell Culture Market encompasses the use of advanced technologies, including 3D cell cultures, to grow cells in controlled environments for research and biopharmaceutical manufacturing. Biopharmaceutical manufacturers employ single-use technologies (SUTs) such as single-use bioreactors (SUBs) to mitigate cross-contamination risk and reduce capital investment and sterilization costs. Operating volume requirements vary, with SUBs offering flexibility for small-scale production. Emerging economies present opportunities for growth due to lower manufacturing costs, but regulatory guidelines must be adhered to. The biopharmaceutical sector's reliance on cell culture technologies has surged during pandemics, highlighting their importance in producing vaccines and therapeutics. Multiple-use bioreactors continue to be used, but the shift towards SUTs is gaining momentum due to cost advantages and improved process efficiency.
In-depth analysis on market researh, compeitive landscape, Segment wise regional analysis, Historic (2018- 2022) and forecast 2(023- 2027)-.View Sample Report
Market Segmentation
This Cell Culture Market report extensively covers market segmentation by Product (Consumables, Equipment) End-user (Pharma and biotech companies, Hospitals, Research and academic Institutes, Others) Geography (North America, Europe, Asia, Rest of World (ROW))
Market Segmentation by Product
The cell culture market encompasses plastic consumables as a significant segment. These consist of vessels made from PE, PP, and ethylene vinyl alcohol, as well as nylon accessories. Sera, media, and reagents are essential components, along with single-use bioprocessing systems. Despite their high usage and revenue generation, plastic waste from these consumables contributes to environmental impact. Disposal of solid waste materials is a concern. Recycling initiatives offer potential solutions, reducing environmental harm. Laboratories utilize various consumables, including antibiotics, antimycotics, and cell culture reagents, in addition to plastic vessels and accessories.
The report also covers details on market segmentation with regional wise- .purchasing a report
Drivering Factors impact the market
The cell culture market, a significant segment in the biopharmaceutical domain, experiences continuous growth due to the increasing demand for mammalian cell lines in biopharmaceuticals and alternative medicines. Notable cell lines include the Chinese Hamster Ovary (CHO) cells. This industry caters to various applications, such as grafting procedures and personalized therapy. A recent research study indicates a substantial revenue growth in the cell culture market, driven by industry trends like the increasing focus on biopharmaceuticals and cell-based research. Pricing analysis and patent analysis are crucial factors influencing market dynamics. Key stakeholders include research institutions, pharmaceutical companies, and biotech firms. Buying behavior is influenced by factors like product quality, pricing, and technological advancements. The market's future prospects are promising, with potential opportunities in emerging applications and collaborations.
The report also covers information on upcoming trends and challenges. Explore detailed information by.purchasing a report
About US
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article